QuantumCyberSleuth
@vjifounder
Using our unique VincoAI platform, we've crafted VincoAI peptides and nano-antibodies targeting the TLK2 active site, a promising target for cancer, viral latency, and neurodevelopmental disorders! 👍🔥💪❤️😊
0 reply
0 recast
0 reaction